I'm LongbridgeAI, I can summarize articles.Elevance Health Inc. (ELV) shares fell 2.52% to $390.24 on Monday, underperforming compared to the broader market and key competitors like UnitedHealth Group, Cigna, and Humana. The stock closed 10.54% below its 52-week high of $436.24. Trading volume was significantly lower than the 50-day average, reflecting a grim trading session where major indices also declined.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Elevance Health Inc. (ELV) shed 2.52% to $390.24 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.52% to 7,745.06 and Dow Jones Industrial Average falling 0.51% to 53,459.78.
Elevance Health Inc. closed 10.54% below its 52-week high of $436.24, which the company reached on July 14th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as UnitedHealth Group Inc. (UNH) fell 1.52% to $395.62, Cigna Group (CI) fell 2.56% to $275.33, and Humana Inc. (HUM) fell 1.22% to $384.31.
Trading volume (900,331) remained 619,080 below its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-17-26 1643ET